Abstract:Background and Objective: Liver fibrosis is a disease with characteristics of an aberrant wound healing response. Fibrosis is commonly the end-stage for chronic liver diseases like alcohol-associated liver disease (ALD), metabolic-associated liver disease, viral hepatitis, and hepatic autoimmune disease. Innate immunity contributes to the progression of many diseases through multiple mechanisms including production of pro-inflammatory mediators, leukocyte infiltration and tissue injury. Chemokines and their receptors orchestrate accumulation and activation of immune cells in tissues and are associated with multiple liver diseases; however, much less is known about their potential roles in liver fibrosis. This is a narrative review of current knowledge of the relationship of chemokine biology to liver fibrosis with insights into potential future therapeutic opportunities that can be explored in the future.Methods: A comprehensive literature review was performed searching PubMed for relevant English studies and texts regarding chemokine biology, chronic liver disease and liver fibrosis published between 1993 and 2021. The review was written and constructed to detail the intriguing chemokine biology, the relation of chemokines to tissue injury and resolution, and identify areas of discovery for fibrosis treatment.Key Content and Findings: Chemokines are implicated in many chronic liver diseases, regardless of etiology. Most of these diseases will progress to fibrosis without appropriate treatment. The contributions of chemokines to liver disease and fibrosis are diverse and include canonical roles of modulating hepatic inflammation as well as directly contributing to fibrosis via activation of hepatic stellate cells (HSCs). Limited clinical evidence suggests that targeting chemokines in certain liver diseases might provide a therapeutic benefit to patients with hepatic fibrosis.Conclusions: The chemokine system of ligands and receptors is a complex network of inflammatory signals in nearly all diseases. The specific sources of chemokines and cellular targets lend unique pathophysiological consequences to chronic liver diseases and established fibrosis. Although most chemokines are pro-inflammatory and contribute to tissue injury, others likely aid in the resolution of established fibrosis. To date, very few targeted therapies exist for the chemokine system and liver disease and/or fibrosis, and further study could identify viable treatment options to improve outcomes in patients with end-stage liver disease.

Novel Immune Subsets and Related Cytokines: Emerging Players in the Progression of Liver Fibrosis

Ongoing involvers and promising therapeutic targets of hepatic fibrosis: The hepatic immune microenvironment

The Important Roles of Natural Killer Cells in Liver Fibrosis

Modification of Chemokine Pathways and Immune Cell Infiltration as a Novel Therapeutic Approach in Liver Inflammation and Fibrosis

Immunoregulation of Liver Fibrosis: New Opportunities for Antifibrotic Therapy

Liver fibrosis: mechanisms of immune-mediated liver injury

Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets

Regulatory T cells (Tregs) in liver fibrosis

Research Advances in Immune Cellular Pathogenesis in Liver Fibrosis

Novel insights into the role of immunomodulatory extracellular vesicles in the pathogenesis of liver fibrosis

Role of the chemokine system in liver fibrosis: a narrative review

Crosstalk Between Autophagy and Innate Immunity: A Pivotal Role in Hepatic Fibrosis

Research progress on roles of immune factors in development of hepatic fibrosis

Novel Therapeutic Targets in Liver Fibrosis

Clinical significance of the immune cell landscape in hepatocellular carcinoma patients with different degrees of fibrosis

Liver Fibrosis Resolution: from Molecular Mechanisms to Therapeutic Opportunities

Regulation of Progression and Resolution of Liver Fibrosis by Immune Cells

Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy

Liver Disease: Induction, Progression, Immunological Mechanisms, and Therapeutic Interventions

Interorgan communication with the liver: novel mechanisms and therapeutic targets

From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells